Deals
Cinven Weighs Take Private of Laboratory Firm Synlab
- Demand for testing facilities has fallen post-pandemic
- Move would reverse Synlab IPO in March 2021 by Cinven, others
This article is for subscribers only.
Cinven has made an indicative offer to take Synlab AG private in a roughly €2.2 billion ($2.4 billion) deal, just two years after listing the German laboratory operator that’s now battling with reduced demand for its testing facilities.
The UK buyout firm has submitted a non-binding expression of interest to acquire Frankfurt-listed Synlab at €10 a share, according to a statement on Monday that confirmed an earlier Bloomberg News report.